SONALASENSE, INC.

Oakland, CA · Founded 2019 · CIK 0001825955 · Medtech · Private

MRI-guided focused ultrasound device combined with 5-aminolevulinic acid drug for sonodynamic therapy of glioblastoma

sonalasense.com →
Grants
$4.2M
5 awards
Sector median: 1
Raised
$35M
4 Form D · Nov 2023
35 months since last filing
Contracts
—
No federal contracts on record
Patents
5
0 granted · 5 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$999,980
Private capital raisedForm D · SEC$3,933,400
Private capital raisedForm D · SEC$20,093,202
Federal grantDepartment of Health and Human Services · Phase II · Evaluation of the safety and efficacy of non-invasive sonodynamic therapy for diffuse intrinsic pontine glioma$938,955
Federal grantDepartment of Health and Human Services · Phase II · Sonodynamic therapy using MRI-guided focused ultrasound in combination with 5-aminolevulinic acid to treat recurrent glioblastoma multiforme$694,814
Federal grantDepartment of Health and Human Services · Phase II · Sonodynamic therapy using MRI-guided focused ultrasound in combination with 5-aminolevulinic acid to treat recurrent glioblastoma multiforme$694,814
Federal grantDepartment of Health and Human Services · Phase II · Evaluation of the safety and efficacy of non-invasive sonodynamic therapy for diffuse intrinsic pontine glioma$1,061,045
Private capital raisedForm D · SEC$9,765,000
Federal grantDepartment of Health and Human Services · Phase II · Sonodynamic therapy using MRI-guided focused ultrasound in combination with 5-aminolevulinic acid to treat recurrent glioblastoma multiforme$796,215
Federal grant · SBIR/STTRForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1161BLOCKSYNOP INC——
1162Levita Magnetics International Corp.—$51M
1163Spiral Therapeutics Inc—$37M
1164SONALASENSE, INC.—$35M
1165LATDE DIAGNOSTICS CORP.——
1166AUTHENTAG LLC——
1167Logiq.ai Inc.—$1.5M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Mark de SouzaDirector · Executive Officer
  • MARK DE SOUZADirector · Executive Officer
  • Stuart MarcusDirector · Executive Officer
  • STUART MARCUSDirector · Executive Officer
  • VINCENT SAIDirector

Patents

USPTO · 0 granted of 5
  • Metabolic Targeting Of Low Grade Tumorsapplication
  • Metabolic Targeting Of Low Grade Tumorsapplication
  • Metabolic Targeting Of Low Grade Tumorsapplication
  • Sonosensitizationapplication
  • Sonosensitizationapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.